Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma.

Johnson DB, Puzanov I, Kelley MC
Immunotherapy. 2015 7 (6): 611-9

PMID: 26098919 · PMCID: PMC4519012 · DOI:10.2217/imt.15.35

MeSH Terms (7)

Animals Clinical Trials, Phase II as Topic Herpesviridae Humans Melanoma Oncolytic Virotherapy Oncolytic Viruses

Connections (1)

This publication is referenced by other Labnodes entities:

Links